Menu

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6086867)

Ustekinumab solution for Intravenous infusion stelara 130 mg 26 ml,Ustekinumab solution for Subcuta

Goods
Qty:990
EMD: ₹31,811
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6086867)

Tender Timeline

Tender Issue
April 26, 2025 at 9:47 AM

Tender Title: Dinoprostone
Tender Reference Number: GEM/2025/B/6086867
Issuing Authority: Department of Military Affairs, Ministry of Defence

Scope of Work and Objectives

The Department of Military Affairs invites bids for the supply of Ustekinumab solutions designated for intravenous infusion and subcutaneous administration. The specific requirements include:

  • Ustekinumab solution for intravenous infusion (specifically Stelara 130 mg in a 26 ml solution)
  • Ustekinumab solution for subcutaneous administration (Stelara 90 mg in a 1 ml solution)
  • Provision for Recombinant Factor VIII Human Plasma Albumin Free products, specifically designed for viral inactivation processes.

The objective of this tender is to ensure that high-quality, safe, and compliant pharmaceutical products are available for the healthcare initiatives within military operations.

Eligibility Criteria

To participate in this tender, bidders must meet the following eligibility criteria:

  • Must be a registered legal entity with appropriate pharmaceutical certifications.
  • Producers and suppliers should have prior experience in handling similar pharmaceutical supplies.
  • Bidders should comply with all local governmental regulations applicable to pharmaceutical products.

Technical Requirements

Bidders are required to provide detailed specifications which must include:

  • All technical certificates for the proposed Ustekinumab solutions and Recombinant Factor VIII products.
  • Evidence of compliance with quality standards as set by health authorities and include any internationally recognized certifications (e.g., ISO, WHO prequalification).
  • A detailed manufacturing and quality assurance process that adheres to Good Manufacturing Practices (GMP).

Financial Requirements

Bidders will need to provide:

  • A detailed pricing structure, including all applicable taxes and delivery charges.
  • Earnest Money Deposit (EMD) which is mandatory for bid submission and shows commitment to fulfilling the tender terms.

Document Submission Details

Interested bidders are required to submit their technical and financial proposals as part of their bids. All documents must be formatted in either PDF or Word formats and submitted electronically via the designated procurement portal before the tender deadline.

Special Provisions

This tender includes provisions to support Micro, Small, and Medium Enterprises (MSEs) and startups, reinforcing the government’s commitment to enhancing local manufacturing and economy. Bidders from these categories may be entitled to expedited processing or reduced evaluation criteria, fostering more inclusivity in procurement.

Evaluation Process

The evaluation of submitted tenders will take place in a structured manner, considering both technical and financial proposals. The criteria for evaluation will include:

  • Compliance with the technical specifications
  • Cost-effectiveness of financial proposals
  • Overall supplier reliability and past performance records

Delivery Locations

The successful bidder(s) will deliver the products to designated military healthcare facilities throughout the region specified during the bidding process. All logistics must comply with national standards, ensuring timely and safe product delivery.

Contact Information

For queries related to the tender, please contact the representative from the Department of Military Affairs. Ensure that all communication adheres to guidelines laid out in the official documentation to maintain clarity and transparency during the bidding process.


General Information

Item Category
Ustekinumab solution for Intravenous infusion stelara 130 mg 26 ml , Ustekinumab solution for Subcutaneous stelara 90 mg 1 ml , Recombinant Factor VIII Human Plasma Albumin Free Viral Inactivation through solvent detergent treatment step Vial of 500 IU , Recombinant factor VIII Extended half life 1000 unit Vial , Dinoprostone PEG2 10 mg Pessary , Inj Faricimab
Ministry Name
Organisation Name
City

Financial Information

EMD Amount
₹31,811.00
OEM Average Turnover
₹28.00 Lakh (s)
Minimum Turnover
₹28.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
30 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
3 Days

Tender Documents

4 Documents
GeM-Bidding-7680135.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Ketamine HCl 50 mg per ml 2 ml Inj,Bupivacaine HCl 5 mg per ml Inj,Fentanyl Citrate 50mcg per ml 2

GEM
Goods
Qty:33.9K
4 Files
Indian Army
KARGIL, JAMMU & KASHMIR
Boq › Boql
Ketamine HCl 50 mg per ml 2 ml Inj , Bupivacaine HCl 5 mg per ml Inj , Fentanyl Citrate 50mcg per ml 2 ml Inj , Dexamethasone 0.5 mg Tab , Baclofen 10 mg Tab , Inj Tenecteplase 20 mg , Enoxaparin 40 mg per 0.4ml Inj , Cilnidipine 5 mg Tab , Cap Probiotic , Itraconazole 100mg Cap , Oral Rehydration powder sachet of 20.5 g , Thyroxine Sodium 0.1mg Tab , Fluticasone Propionate 50 mcg BP Nasal Spray , Clonazepam 0.5 mg Tab , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg , Nortriptyline 25 mg Tab , Levo Salbutamol Sulphate 2.5 ml containing 1.25 mg Respule , Micronized Purified Flavonoid Fraction of rutaceae 500mg Tab , Tamsulosin HCl 0.4mg Cap , B1 50 mg Inj , Formeterol 6mcg and Budesonide 400 mcgC FC Free MDI 120 Meter dose , Levo- Salbutamol 1.25mg with Ipratropium 500 mcg in 2.5 ml Respule , Fexofenadine Hydrochloride Tab 120 mg , Amoxycillin 1g with Clavulanic Acid 200mg 1.2 gm Inj , Cefoperazone Sodium 1gm and sulbactum Sod 1gm Inj , Teicoplanin 400 mg Inj , Vancomycin CP 500 mg Inj , Meropenem 500 mg Inj , Gauze Surgical Open Wove Unmedicated 60 cm wide , HIV antibody 1 and 2 detection rapid test kit , Troponin T Test card , Rapid card screening for HBV kit of 50 test , Rapid card screening for HCV kit of 50 test , Tab Pantoprazole with Domperidone , Lyse solution, bott of 500ml , Cell Pack pack of 20 ltr , Tab Nilotinib 200mg , Syp Disodium Hydrogen Alkasol, bott of 100 ml , Dengue test card kit of 20 test , Malaria test card kit of 50 test , Typhi Dot test card kit of 50 test , Glucose strip Accu check , Glucometer Cell , Cap Diacerine 50mg , Medical Dry Film 10 inch and 8 inch Fujifilm , Sample Cup , Roter 180 Fully Automatic Machine Erba , Sodium Potassium Chloride kit 180 Fully Automatic , Cholestrol Kit 180 Fully Automatic Erba , Lipase Kit 180 Fully Automatic Erba , CKMB Kit 180 Fully Automatic Erba , CRP Kit 180 Fully Automatic Erba , LDH Kit 180 Fully Automatic Erba , Multi Cal Kit 180 Fully Automatic Erba , ERBA Auto Wash 180 Fully Automatic Erba , ERBA Norm 180 Fully Automatic Erba , ERBA Path 180 Fully Automatic Erba
April 26, 2025
May 17, 2025 at 12:00 PM
View Details

Bupivacaine HCl 5mg ml heavy 4ml Inj,Inj Atropin Sulphate 0 point 6mg,Chloroxylenol sol pot Hydroxi

GEM
Goods
Qty:1.2L
4 Files
Indian Army
AMBALA, HARYANA
Boq › Boql
Bupivacaine HCl 5mg ml heavy 4ml Inj , Inj Atropin Sulphate 0 point 6mg , Chloroxylenol sol pot Hydroxide 13 point 6g Chloroxylenol , Carboprost Tromethamine 250 mcg ml 1ml Inj , Methylergometrine maleate 0 point 2mg , Inj Diclofenac Aqueous AQ 75 mg 1 ml amp , Misoprostol 200 mcg Tab , Diclofenac suppositories 100 mg , Gliclazide 40 mg Tab , Gliclazide 80 mg Tab , Tab Repaglinide 1 mg , Tab Repaglinide 2 mg , Voglibose 0 point 3 mg Tab , Labetalol HCl 100 mg Tab , Propranolol 40 mg Tab , Telmisartan 80 mg Tab , Tab Clinidipine 10mg , Sodium Valproate 500mg ml Inj , Midazolam Nasal spray 0 point 5 mg spray 5ml bottle , Donepezil 5 mg Tab , Levodopa 100 mg plus Carbidopa 10 mg Tab , Memantine 5 mg Tab , Tab Desidustat 100 mg , Topiramate 50 mg , Xylometazoline HCl 0 point 05 percent nasal solution , N Acetyl Cysteine inj , Pheniramine Meleate Inj 22 point 75 mg per ml amp of 2 ml , Clindamycin plus Clotrimazle veginal pessary , Bisoprolol 2 point 5 mg Tab , Bisoprolol 5 mg Tab , Fenofibrate 160 mg Tab , Nifedipine Retard 20 mg Cap , Pralidoxime 500mg 20ml Inj , Prazosin 5 mg sustained release slow release Tab , Ranolazine 500 mg Tab , Rivaroxaban 20mg Tab , Sodium Bicarbonate 1000 mg Tab , Trimetazidine 20 mg Tab , Trimetazidine 35 mg MR Tab , Alprazolam 0 point 25 mg Tab , Alprazolam 0 point 5 mg Tab , Aripiprazole 10 mg Tab , Buspirone HCl 10 mg Tab , Chloridiazepoxide 10mg Tab , Clonazepam 0 point 5 mg Tab , Doxepin 25 mg Cap , Duloxetine 20 mg Tab , Vitamin D3 400 IU ml Drops 15ml , Inj Colistimethate 4 point 5 MU , Azithromycin 500 mg Inj , Fluvoxamine 50 mg Cap , Levodopa 100 mg plus Carbidopa 25 mg Tab
April 25, 2025
May 16, 2025 at 10:00 AM
View Details

Succinylchloline Chloride 50 mg per ml, 2 ml Inj,Cap Tacrolimus 0.25 mg,Flavoxate 200mg Tab,Erythro

GEM
Goods
Qty:47.3K
4 Files
Indian Navy
UTTARA KANNADA, KARNATAKA
Boq › Boql
Succinylchloline Chloride 50 mg per ml, 2 ml Inj , Cap Tacrolimus 0.25 mg , Flavoxate 200mg Tab , Erythropoeitin Human Recombinant 4000 IU , Papaverine Hydrochloride 50 mg, 2 ml Inj , Sevelamer Carbonate Sachet 800mg , Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen , Gentamicin sulphate 0.3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml , Brimonidine Tartrate 0.2 percent, Eye drops , Clobazam 5 mg Tab , Lorazepam 2 mg per ml, 2 ml Inj , Gabapentin 300 mg Cap or Tab , Sodium Valproate 100 mg per ml Inj , Lamotrigine 25 mg Tab , Sumatriptan 50 mg Tab , Topiramate 25 mg Tab , Nimodipine 30 mg Tab , Canagliflozin 100mg tab , Carbimazole 20 mg Tab , Tab Tenofovir 300mg , Tab Entacavir 0.5mg , Omeprazole 20 mg Cap , Pantoprazole 40mg Inj , Ranitidine HCl 50 mg, 2 ml Inj , Metoclopramide syrup 5mg per 5ml bott of 30ml , Hydrocortisone Enema 10 percentage , Dicyclomine HCl 20 mg Inj , Tab or Cap Dicyclomine 10mg , Bisacodyl 5 mg Tab , Sodium phosphate solution 45 ml, each Pack of 2 bottle , Tab Dapagliflozin 10mg , Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m... , Baclofen XL 30 mg Tab , Clozapine 50 mg Tab , Ranolazine 500 mg Tab , Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0.03 mg, Norgestrel 0.30 mg Tab
April 25, 2025
May 16, 2025 at 10:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity with the necessary pharmaceutical certifications, demonstrating experience in supplying similar pharmaceutical products, and compliance with local governmental regulations applicable to pharmaceutical supplies.

Bid submissions must include technical certificates for Ustekinumab solutions and the Recombinant Factor VIII products, compliance with quality standards such as ISO, and proof of adherence to Good Manufacturing Practices (GMP).

To register for this tender, bidders must create an account on the designated procurement portal. Accepted document formats for submission are PDF and Word files. It is important to ensure all documents are complete and compliant with the tender specifications.

The Earnest Money Deposit (EMD) amount is specified in the tender documentation and serves as a commitment from the bidders. Additionally, successful bidders will be required to submit a performance security, typically a percentage of the contract value, to ensure fulfillment of the contract terms.

The evaluation process will assess both technical and financial aspects of the bids. Factors such as compliance with technical standards, competitive pricing, and supplier reliability and past performance will be critical in determining the winning bid. Notifications of results will be communicated through official channels as specified in the documentation.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders